The Medicines Act 101 of 1965 has changed to include the judgement for “personal use” that was obtained in 2018. There is no more Cannabis research permit under the Section 22 (9) a (I) (ii) as the: 

1. “Cannabis plant” has been removed from Schedule 7 of the act; 2. as well as “delta 9 tetrahydrocannabinol (THC)” and “Drobaninol (synthetic THC)” has been removed from Schedule 7 and placed in Schedule 6; 3. “Cannabidiol (CBD)” has been alternatively listed in Schedule 4, and in Schedule 0 as complementary medication. The impact thereof was that according to Section 22 (9) (a) (i) research permits are issued only for Schedule 7 products. The structure has now changed to allow the following: 

1. Hemp Grow Permit: There is now an official Hemp Grow permit issued on Sativa L Hemp plants for the total Hectares of the Farm or Plot and limited: a. 500kg per hectare; b. Hemp fibre only; c. THC content of products allowed but regulated and reported on after finalising grow permit; d. No medicinal processing of cannabinoid containing material. 2. A “new” Research permit structure has been proposed and that could be issued under Section 22c and d of the Act. The research permit would not be subjected to site inspections and a prolonged validation period. A special ethics committee would validate and approve the issuance. The full License fees pertaining to this license would be payable, but the research permit would be issued subject to the applicant being allowed to do research, cultivation, extraction, processing, market testing (sales), etc. 3. The Section 22C & D full license application would still be subjected to the full validation protocols of site visits, approvals, etc.

License Applications

SAHPRA Section 22C Research Permit

SAHPRA Section 22C Full Application

Hemp Growers Permit (The Department of Agriculture, Forestry and Fisheries)

Consulting Packages

Retail Consulting

Legal Consulting

Strategy and Business Development